THE im balance of T-h e lpe r (Th ) lym p h o cyte cyto kine p r oduction m ay p lay an im p o rtan t ro le in im m un op ath oge n es is of p e rs is ten t h ep atitis C virus (HCV
Introduction
He patitis C virus (HCV) infec tion has be en confirmed to be the major ae tiologic age nt for posttransfusion hepatitis all ove r the w orld. One of the charac te ristic fe ature s is at least half of the infe ction to be c ome chronic. 1 -3 The high mutational rate of the viral ge nome is cons idere d to be re sponsible for persiste nt HCV infec tion. 3 The inability of the host immune function to eliminate an organism is also an important cause for persiste ntive form of infe c tion. 4 How e ver, little has be en learned about the host ce llular immune re sponse to HCV. The role of the immunore gulatory cytokines in chronic HCV infec tion is re c ently be ing stressed. 5, 6 In this study, to be tter know the profiles of cytokines production in individuals w ith chronic HCV infec tion, w e me asured serum levels of T-helpe r lymphocytes (Th)1 cytokines interferon gamma (IFN-g ), inte rleukin (IL)-2, and Th2 cytokines IL-4, IL-10 in such patie nts.
Subjects and Methods

Subjects
Eighte en patie nts w ith chronic HCV infe ction w ere include d in this study. The diagnosis of chronic HCV infec tion w as based on the seropositivity of HCV spe cific antib ody and HCV-RNA for at least 6 months of 2 times dete ction. There w as no se rologic e vide nce of c o-infe ction w ith othe r hepatotropic viruse s. Other possible c ause s of hepatocellular injury, such as alc ohol, drugs and autoimmune diseases w e re also ex cluded. No immunore gulatory agents w e re administe re d in re c ent 3 months be fore enrolme nt. The charac te ristics of 18 chronic HCV infec te d individuals w e re summarized in Table 1 .
As normal controls, 11 healthy subje cts w ho w ere ne gative for both serum anti-HCV and hepatitis B virus (HBV) marke rs w ere selec te d w ithout a clinic al history of he patitis and w ithout symptoms or signs of live r dise as es (seven males and four females; me an age 32 ye ars, range 20-47 ye ars). Also, 10 chronic he patitis B patients (seven male s and thre e females, me an age 38 ye ars, range 23-56 years) w ith no se rologic evide nce of HCV infec tion w ere re c ruited as disease controls, w ho had se rop ositivity of HBV markers and abnormal liver te sts for more than 6 months.
Methods
Serologic dete c tions of HBV markers , anti-HCV (a se cond-gene ration te st) w ere carried out using comme rc ially available e nzyme -linked immunosorbe nt assay (ELISA) kits (Sino-Americ an Biote chnology Company, Louyan, China). The proce dures w ere p erforme d acc ording to the manufac ture r's instruction. Serum HCV-RNA w as de te rmined by re verse transc ription p olyme rase chain re ac tion (RT-PCR). Briefly, RNA w as ex tracte d from the samples by single ste p me thod as de sc ribe d pre viously. 7 The amplific ation w as done after an initial denaturation ste p (94°C, 5 min) by 32 cycles (94°C, 30 s; 58°C, 30 s; 72°C, 1 min) and 5 min at 72°C in a the rmocycler (PerkinElmer Ce tus, Changsha Branch, Changsha, China). The amplified cDNA fragme nts w ere analysed on a 1.5% agarose ge l. The bands w e re visualized by ethidium bromide staining.
Quantification of se rum c ytokines w as measured by ELISA using comme rc ially available kits (Genzyme, She nzheng Branch, Shenzhe ng, China). The se ra w ere stored at -30°C until assay (in 3 months) and each sample w as ex amined in dup lic ate. The assays w e re performe d follow ing the manufacturer's instruction.
Statistics
Data w ere analyse d by non-parame tric te st and ex pre sse d as mean ± standard division.
Results
The serum le vels of IFN-g , IL-2, IL-4 and IL-10 w e re me asured in patients w ith HCV or HBV infection and normal c ontrols. As show n in Table 2 X . G. Fa n et al.
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Mediators of Inflammation · Vol 7 · 1998 In chronic HBV infec te d patie nts, se rum levels of IFN-g , IL-4 and IL-10 w e re highe r than those in normal controls, though only IL-10 level re ache d a statistical differe nc e ( Table 2 ). Furthe rmore , the elevate d level of serum IL-10 w as smalle r in HBV infecte d patients compared w ith that in HCV infecte d p atie nts.
The se rum le ve ls of IFN-g , IL-2, IL-4 and IL-10 have not be e n found to be re late d to se rum activity of alanine transaminase (ALT) in HCV infec te d individuals (Table 3) .
Discussion
It has be e n de monstrated that Th lymphocyte s may be subdivide d into Th1 and Th2 cells based on the distinc t patte rns of cytokine produc tion. 8 Th1 cells produce IFN-g , IL-2 and lymphotox in w hich promote ce ll-mediate d effe ctor re spons es; w he re as Th2 cells produce IL-4, IL-5, IL-6 and IL-10 cytokines w hich influenc e B-c ell development and c an augme nt humoral re sponses. Cytokines re leased by one type of Th lymphocyte population can dow n-re gulate the functions of anothe r Th population. Th1 re sponse s are associated w ith immunity or re sis tance to infe ction, w hile Th2 re sponses are as sociated w ith the progre ssion or p ersis te nc e of infe ction. 9 ,10 A shift of Th1 to Th2 re sponse s has be en implic ate d in the pathoge nesis of some infe ctious diseases, such as human immunode fic ie ncy virus infe ction, mycobac te rial and protozoal diseases. 4,1 0 Inflammatory cytokines play an important role in pathogene sis of he patitis B.
1 1 How ever, the re ports on the manner of c ytokine s in chronic HCV infe ction are rare. The c urre nt study show e d that the incre ase d production of Th1 (IFN-g and IL-2) and Th2 (IL-4 and IL-10) cytokines are pre sent in HCV infec tion, sugge sting Th ce lls are activate d in vivo due to HCV infec tion. This re sults is in agre eme nt w ith another observation re porte d by Cac ciare lli. 6 It is also note d that the ele vate d le vels of Th2 c ytokine s are gre ater than Th1 cytokines in HCV infec tion. In view of ne gative re gulation of Th2 cytokines for immune func tions, 4 w e cons ide r that e nhanc ed Th2 re ac tion is at least partly re sp onsible for immunopathoge ne sis of chronic HCV infec tion. We also propose that enhance d Th2 re sponse s in HCV infe ction may allow the human host to suppre ss the inflammatory/ immune re sponses, 12 ,13 re sulting in re ducing the he patic tissue injury through dow n-re gulation of the inflammatory/immune re ac tion and leading to inability to e liminate the virus. This is one possible ex planation w hy HCV infection te nds to be a chronic condition. To further e luc idate the role of these cytokines in immunopathoge ne sis of chronic HCV infec tion, the levels of mRNA ex pre ssion for intrahe patic Th cytokines are currently pe rforming.
Similarly, an incre as ed production of IL-10 w as observe d for chronic HBV infec tion in the study. Based on the re sults in this study, enhanc ed Th2 re sponses, how e ve r, are obviously w eake r in HBV infec tion than in HCV infe ction. It is possibly one of the c ause s that the chronic feature is more c ommon in HCV infec tion than in HBV infec tion. 
